Clinical Trials Browser

Completed × avelumab × Head & Neck × Clear all

NCT04601402 2023-08-08

GEN-001 (Live Biotherapeutic Product) and Avelumab Combination Study for Patients With Solid Tumors Who Have Progressed on Anti-PD-(L)1 Therapy

Phase 1 Completed

GenitourinaryHead & NeckThoracic

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Non-Small-Cell Lung, Carcinoma, Transitional Cell

NCT04065555 2022-07-29

Intratumoral Microdosing of TAK-981 in Head and Neck Cancer

Phase EARLY_PHASE1 Completed

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms

NCT02938273 2019-12-11

Bioimmunoradiotherapy (Cetuximab/RT/Avelumab)

Phase 1 Completed

Squamous Cell Carcinoma of Head and Neck